Journal Logo

Articles by V. I. Gaidzik

MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA (AML) WITH T(8;21)(Q22;Q22.1); RUNX1-RUNX1T1: RESULTS OF THE AML STUDY GROUP (AMLSG): S1616

Rücker, F. G.; Agrawal, M.; Corbacioglu, A.; More

HemaSphere. 3:745-746, June 2019.